Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
IONS
Stock Latest News
The Fly
Nike downgraded, IBM initiated: Wall Street’s top analyst calls
3d ago
BDX
CCC
Premium
The Fly
Ionis Pharmaceuticals resumed with an Outperform at Raymond James
3d ago
IONS
Premium
The Fly
Ionis Pharmaceuticals price target raised to $111 from $100 at BofA
4d ago
IONS
Premium
Company Announcements
Ionis Extends Donidalorsen Into Children: What the New HAE Trial Means for Investors
5d ago
IONS
Premium
The Fly
Ionis Pharmaceuticals management to meet with Oppenheimer
10d ago
IONS
Premium
Ratings
Ionis: Olezarsen’s Expanded Global Opportunity and Strengthened Royalty Streams Support Reiterated Buy and $120 Target
13d ago
IONS
Premium
The Fly
Arrowhead price target lowered to $81 from $84 at BofA
17d ago
ARWR
IONS
Premium
The Fly
Ionis Pharmaceuticals price target raised to $106 from $95 at Barclays
18d ago
IONS
Premium
The Fly
Ionis Pharmaceuticals price target raised to $83 from $77 at Stifel
18d ago
IONS
Premium
The Fly
Ionis Pharmaceuticals price target raised to $120 from $110 at H.C. Wainwright
18d ago
IONS
Premium
The Fly
Ionis announces NDA for zilganersen accepted by U.S. FDA for Priority Review
21d ago
IONS
Premium
Market News
Cathie Wood Invests Over $10M in CRISPR and PAYP Stocks, Trims Stakes in TER and IONS
1M ago
TEM
TXG
Premium
Company Announcements
Ionis Pharmaceuticals Announces Board Retirements and New Appointment
1M ago
8K
IONS
Premium
The Fly
Ionis Pharmaceuticals price target raised to $100 from $87 at Piper Sandler
1M ago
IONS
Premium
The Fly
Ionis Pharmaceuticals announces olezarsen sNDA accepted for FDA priority review
2M ago
IONS
Premium
The Fly
Ionis Pharmaceuticals price target raised to $77 from $73 at Stifel
2M ago
IONS
Premium
Company Announcements
Ionis Pharmaceuticals Earnings Call Highlights Surging Momentum
2M ago
IONS
Premium
Ratings
Ionis Pharmaceuticals: Accelerating Commercial Momentum, Conservative Guidance, and Late-Stage Pipeline Catalysts Underpin Buy Rating
2M ago
IONS
Premium
Ratings
Ionis Pharmaceuticals: Strong 4Q25 Beat and Catalyst-Rich 2026 Underpin Raised Buy Rating and $103 Target
2M ago
IONS
Premium
The Fly
Ionis Pharmaceuticals price target raised to $103 from $90 at Needham
2M ago
IONS
Premium
Ratings
Ionis Pharmaceuticals: Buy Rating Driven by Strong Q4 Beat, Growing Commercial Portfolio, and Pipeline Upside Catalysts
2M ago
IONS
Premium
The Fly
Ionis Pharmaceuticals sees FY26 revenue $800M-$825M, consensus $914.39M
2M ago
IONS
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
